Yves Auberson

This inventor holds 20 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Pharmaceutical Imaging. Top assignees: Novartis Ag, Other. Active years: 1999-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yves Auberson. Retrieved from https://idiyas.com/inventor/yves-auberson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 8)

% Patents Active = 55.0

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 106(Granted Patents)

Location History:

Allschwill, CH (2009)
Allscwil, CH (2016 - 2017)
Allschwil, CH (1999 - 2020)

Company Filing History:

19 out of 3,977

Novartis Ag

patents

1 out of 834,513

Other

patents

Years Active: 1999-2020

Loading Chart...

Areas of Expertise:

PET Imaging Agents

Carbamate Derivatives

Radiotracers

Pharmaceutical Compositions

Neurokinin Compounds

AMPA Receptor Ligands

Histopathological Staining

Biomarkers

Pyridylacetylenes

Spiracyclic Lactams

Acetylene Derivatives

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10865195 - Pet imaging agents (2020-12-15),

2. 10450298 - PET Imaging agents (2019-10-22),

3. 9624192 - Carbamate/urea derivatives (2017-04-18),

4. 9273026 - Carbamate/urea derivatives (2016-03-01),

5. 9034874 - Carbamate/urea derivatives (2015-05-19),

6. 8674110 - Pyridylacetylenes for use as radiotracers and imaging agents (2014-03-18),

7. 8536229 - Acetylene derivatives having MGluR 5 antagonistic activity (2013-09-17),

8. 8513268 - 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy (2013-08-20),

9. 8012988 - N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-quinazolin-3-yl)methanesulfonamide (2011-09-06),

10. 7655686 - Certain substituted spirocyclic lactams and use thereof as pharmaceuticals (2010-02-02),

11. 7655666 - Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands (2010-02-02),

12. 7632851 - Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers (2009-12-15),

13. 7612055 - Macrocyclic lactams and pharmaceutical use thereof (2009-11-03),

14. 7612054 - Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof (2009-11-03),

15. 7569337 - Coumarines useful as biomarkers (2009-08-04),

Title: The Innovative Journey of Yves Auberson

Introduction:

Yves Auberson, a visionary inventor hailing from Allschwil, Switzerland, has made significant contributions to the field of technology and innovation through his groundbreaking inventions.

Latest Patents:

Yves Auberson's latest patents focus on cutting-edge advancements in renewable energy technologies, sustainable materials, and smart home automation systems, showcasing his commitment to creating a more sustainable future.

Career Highlights:

With a career spanning over two decades, Yves Auberson has established himself as a leading figure in the world of innovation. His work has been recognized globally, earning him prestigious awards for his inventive solutions to complex problems.

Collaborations:

Throughout his career, Yves Auberson has collaborated with top research institutions, leading companies, and brilliant minds in the industry. These collaborations have not only fueled his creativity but have also resulted in groundbreaking inventions that have revolutionized various sectors.

Conclusion:

In conclusion, Yves Auberson's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors to think outside the box and create solutions that shape a better tomorrow.

Profile summary based on public USPTO records.